HK1223610A1 - 取代的 -三嗪- -二酮及其作為類糜蛋白酶抑制劑的用途 - Google Patents
取代的 -三嗪- -二酮及其作為類糜蛋白酶抑制劑的用途Info
- Publication number
- HK1223610A1 HK1223610A1 HK16111803.6A HK16111803A HK1223610A1 HK 1223610 A1 HK1223610 A1 HK 1223610A1 HK 16111803 A HK16111803 A HK 16111803A HK 1223610 A1 HK1223610 A1 HK 1223610A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diones
- triazine
- substituted
- chymase inhibitors
- chymase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13192182 | 2013-11-08 | ||
PCT/EP2014/073799 WO2015067650A1 (de) | 2013-11-08 | 2014-11-05 | Substituierte 1,2,4-triazin-3,5-dione und ihre verwendung als chymase hemmern |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1223610A1 true HK1223610A1 (zh) | 2017-08-04 |
Family
ID=49552232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16111803.6A HK1223610A1 (zh) | 2013-11-08 | 2016-10-13 | 取代的 -三嗪- -二酮及其作為類糜蛋白酶抑制劑的用途 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20160287599A1 (zh) |
EP (1) | EP3066095A1 (zh) |
JP (1) | JP2016535095A (zh) |
CN (1) | CN105899500A (zh) |
CA (1) | CA2929762A1 (zh) |
HK (1) | HK1223610A1 (zh) |
WO (1) | WO2015067650A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3338780A1 (de) | 2016-12-20 | 2018-06-27 | Bayer Pharma Aktiengesellschaft | Verwendung von chymaseinhibitoren zur behandlung von endometriose, post-operativer fibrose und erkrankungen die durch fibrosebildung gekennzeichnet sind |
WO2021000933A1 (zh) * | 2019-07-03 | 2021-01-07 | 南京明德新药研发有限公司 | 作为糜酶抑制剂的嘧啶酮类化合物及其应用 |
CN114671878B (zh) * | 2020-12-25 | 2023-08-04 | 广东东阳光药业有限公司 | 取代的含氮双环化合物及其用途 |
WO2022135514A1 (zh) * | 2020-12-25 | 2022-06-30 | 广东东阳光药业有限公司 | 多取代的尿嘧啶衍生物及其用途 |
WO2023194222A1 (en) | 2022-04-05 | 2023-10-12 | Socpra Sciences Santé Humaines S.E.C. | Inhibitors of chymase for use in the selective resolution of thrombi in thrombotic or thromboembolic disorders |
CN117510426B (zh) * | 2024-01-04 | 2024-04-19 | 山东国邦药业有限公司 | 一种抗球虫类兽药三嗪环的合成方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2181360C2 (ru) * | 1996-09-06 | 2002-04-20 | Ниппон Каяку Кабусики Кайся | Новые производные ацетамида, способ их получения, фармацевтический состав и ингибиторы протеаз на их основе |
AU744739B2 (en) * | 1998-02-17 | 2002-02-28 | Nippon Kayaku Kabushiki Kaisha | Novel acetamide derivative and use thereof |
JP2003342265A (ja) * | 2002-05-22 | 2003-12-03 | Senju Pharmaceut Co Ltd | トリアゾリジン誘導体およびその医薬用途 |
US8501749B2 (en) * | 2009-01-30 | 2013-08-06 | Boehringer Ingelheim International Gmbh | Azaquinazolinediones chymase inhibitors |
UA112897C2 (uk) * | 2012-05-09 | 2016-11-10 | Байєр Фарма Акцієнгезелльшафт | Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань |
-
2014
- 2014-11-05 EP EP14793181.0A patent/EP3066095A1/de not_active Withdrawn
- 2014-11-05 CA CA2929762A patent/CA2929762A1/en not_active Abandoned
- 2014-11-05 US US15/035,171 patent/US20160287599A1/en not_active Abandoned
- 2014-11-05 WO PCT/EP2014/073799 patent/WO2015067650A1/de active Application Filing
- 2014-11-05 CN CN201480072708.6A patent/CN105899500A/zh active Pending
- 2014-11-05 JP JP2016551036A patent/JP2016535095A/ja not_active Withdrawn
-
2016
- 2016-10-13 HK HK16111803.6A patent/HK1223610A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2929762A1 (en) | 2015-05-14 |
CN105899500A (zh) | 2016-08-24 |
JP2016535095A (ja) | 2016-11-10 |
EP3066095A1 (de) | 2016-09-14 |
WO2015067650A1 (de) | 2015-05-14 |
US20160287599A1 (en) | 2016-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267681B (en) | Selective grp94 inhibitors and their uses | |
HK1223089A1 (zh) | 激酶抑制劑及其用途 | |
IL243042A0 (en) | Consequences of aminotriazine and a pharmaceutical preparation containing it | |
IL240196A0 (en) | Amide compounds, preparations containing them and their uses | |
EP3008170A4 (en) | SC-CELLS AND COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF | |
HK1223610A1 (zh) | 取代的 -三嗪- -二酮及其作為類糜蛋白酶抑制劑的用途 | |
HK1212700A1 (zh) | 二氫噠嗪- -二酮衍生物 | |
IL244383A0 (en) | Triazolone compounds and their uses | |
GB2519982B (en) | Fungicidal composition and the use thereof | |
IL241359A0 (en) | Converted indole-5-ol derivatives, preparations containing them and their uses | |
EP2976091C0 (de) | Antioxidativ wirksame zusammensetzung und deren verwendung | |
HK1214258A1 (zh) | 新的 -二氫- -異喹啉- -酮和 -二氫-異吲哚- -酮化合物 | |
HK1213564A1 (zh) | 新的 -二氫- -異喹啉- -酮和 -二氫-異吲哚- -酮化合物 | |
GB2516838B (en) | Fungicidal compositions and their use | |
HK1213556A1 (zh) | 新的 -二氫- -異喹啉- -酮和 -二氫-異吲哚- -酮化合物 | |
EP2985017A4 (en) | COMPOSITION COMPRISING A 1,2-ALKANE POLYOL | |
PT3187049T (pt) | Composição herbicida compreendendo o inibidor cicloxidime de acc | |
AP2016009305A0 (en) | Insecticide compound and the compositions thereof | |
GB201322098D0 (en) | MEK-1, 2 kinase inhibitors | |
GB201321480D0 (en) | The concept screwdriver | |
GB201317232D0 (en) | The frozen asset | |
GB201322568D0 (en) | Taggstar 1 | |
GB201310407D0 (en) | Plantladders 3 | |
GB201310285D0 (en) | Twist-Away 270 |